Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Cohera Medical (Pittsburgh, PA) a commercial-stage biotechnology company focused on wound management, mesh fixation and surgical tissue adhesives, closed a $25M Series C financing. Participants include Kern Whelan Capital.

SironRx Therapeutics (Cleveland, OH) a clinical-stage regenerative therapy company focused on wound repair and scarring prevention, closed a $3.4M Series A financing. Participants include North Coast Angel Fund, Cleveland Clinic, JumpStart, Fletcher Spaght Investments, Glengary, Ohio Tech Angel Fund and Early Stage Partners. Thanx for your patience as we catch-up.

Mosaic Bioscience (Boulder, CO) a development-stage synthetic materials company focused on tissue and bone regeneration, closed a $1M Series A financing. Participants include Morgenthaler, HealthCare Ventures and High Country Venture.

Carmell Therapeutics (Pittsburgh, PA) a development-stage biopharmaceutical company focused on biomaterials for connective tissue repair, closed a $2.4M Series A financing. Participants include Harbor Light Capital Partners, Newlin Investment Company, PLSG Accelerator Fund, Innovation Works, Ariel Savannah Angels and Blue Tree Allied Angels.

CoDa Therapeutics (San Diego, CA) a clinical-stag biopharmaceutical company focused on wound care therapeutics, closed a $19.2M Series B financing. Participants include Domain Associates, GBS Venture Partners and BioPacificVentures.

Neomend (Irvine, CA) a commercial-stage developer of sealant and adhesion-prevemtion products focused on the application to visceral pleura for open thoracotomy, closed a $30M Series D financing. Participants include Clarus Ventures, Sanderling Ventures, Novo Ventures, Vivo Ventures and Prospect Venture Partners.

Spiracur (Redwood City, CA) and early-stage medical device company focused on wound healing, closed a $20.3M Series B financing. Participants include Kleiner Perkins Caufield & Byers, New Leaf Venture Partners and De Novo Ventures.

LifeBond (Israel) a commercial-stage developer of wound-closure and hemostasis biomaterials, closed a $8M Series B financing. Participants include Pitango Venture Capital, GlenRock Israel and The Zitelman Group.

Adhezion Biomedical (Myomissing, PA) an early-stage device company focused on the development differentiated cyanoacrylate-based surgical, wound management and infection prevention technologies closed a $2.1M Series A financing, bringing the round total to $5.3M. Participants include Liberty Venture Partners.

Cohera Medical (Pittsburgh, PA) developer of wound management products and surgical tissue adhesives, closed a $16.1M Series B financing. Participants include Bradford Capital Partners and Kern Whelan Capital.

Celleration (Eden Prairie, MN) development-stage medical device company focused on wound healing, closed a $30M Series D financing. Participants include Venture Investors, Heron Capital and Clarian Health Ventures.

Celleration (Eden Prairie, MN) commercial-stage medical device company focused on non-contact ultrasound device for wound care, closed a $25M Series D financing. Participants include Venture Investors, Upper Lake Growth Capital, Baird Venture Partners, Aavin Equity Advisors, Triathlon Medical Ventures and New Science Ventures.

Celleration (Eden Prairie, MN) developer of non-contact ultrasound devices for wound-care, closed a $25M Series D financing. Participants include Venture Investors, Upper Lake Growth Capital, Baird Venture Partners, Aavin Equity Advisors, Triathlon Medical Ventures and New Science Ventures.

« Previous Entries  Next Page »

to top of page...